Year in Review: 2022
A Note from the Division Chief
Our Division of Pediatric Hematology/Oncology at UPMC Children’s is pleased to share a look back at some of the exciting research and clinical accomplishments of our faculty and staff during 2022.
Our faculty and staff have secured a wide range of important new grants to further their respective research programs, and our division has continued to add new faculty and new clinical programs to better support our pediatric hematology/oncology patients and their families.
As a field and in our division, we do difficult, yet rewarding work each day, grappling with the complex challenges of pediatric cancers and blood disorders, and how to better care for our patients. We look forward to the new year ahead and sharing our contributions with our colleagues around the country.
I invite you to get in touch with our division or our faculty members mentioned below to learn more about their research and clinical work or discuss ways to collaborate in the future.
Respectfully,
UPMC Children’s Ranks as the #6 Best Pediatric Hospital in the U.S.
UPMC Children’s Hospital of Pittsburgh is recognized as one of the top pediatric hospitals in the country, earning the sixth position on the 2022-23 U.S. News & World Report Honor Roll of America’s Best Children’s Hospitals.
The Division of Pediatric Hematology/Oncology ranked #13 in the nation among other pediatric hematology/oncology programs.
UPMC Children’s Named ‘Top Children’s Hospital’ by Leapfrog Group
Highlighting its nationally recognized achievements in patient safety and quality, UPMC Children’s Hospital of Pittsburgh was named one of The Leapfrog Group’s prestigious “Top Children’s Hospitals.” UPMC Children’s is one of only 12 pediatric hospitals in the nation named to this elite class.
On October 4, 2022, the Mario Lemieux Foundation donated $5 Million to UPMC Children’s Hospital Foundation to establish the Pediatric Cancer Research Institute. Under the leadership of Linda McAllister-Lucas, MD, PhD, the Mario Lemieux Institute for Pediatric Cancer Research will push the frontier of childhood cancer research. The institute will focus on supporting future research leaders who will help generate new scientific breakthroughs and cutting-edge clinical trials in pediatric cancer research and translate that research directly to patients.
